Sundar Selvaraj/NBDF LinkedIn
Sep 26, 2025, 10:44
Sundar Selvaraj – A Scientist Advancing Hemophilia A Research While Living with Severe FXIII Deficiency and VWD 2M
National Bleeding Disorders Foundation (NBDF) shared on LinkedIn:
”Researcher. Advocate. Dad.
Sundar Selvaraj brings a unique dual perspective to the LEE Research Advisory Council, as a scientist studying hemophilia A and as someone living with both severe factor XIII deficiency and type 2M von Willebrand disease.
Based in Michigan, he’s committed to advancing biomedical research while ensuring patient voices stay at the center.
Learn more about Sundar.”
More winner stories featured in Hemostasis Today.
-
Jul 6, 2026, 22:54Louise St. Germain Bannon: I Wanted to Recognize the Incredible Staff Behind ISTH 2026
-
Jul 6, 2026, 21:46Armghan Ans: UPMC Washington Stroke Program Earns AHA Gold Plus Award for 16th Consecutive Year
-
Jul 6, 2026, 20:31Manik Madaan: Master Transfusion Reactions for USMLE In Less Than 60 Seconds
-
Jul 6, 2026, 19:25Ambreen Kashif: Highlighting the Impact of Temporary Donor Deferrals on Donor Retention
-
Jul 6, 2026, 19:23Rob Mac Sweeney: Anticoagulation Strategies for Cardiopulmonary Bypass in Heparin-Induced Thrombocytopenia
-
Jul 6, 2026, 19:22Nthabiseng Bapela: Interpreting INR in Patients on Warfarin – A Practical Clinical Framework
-
Jul 6, 2026, 19:20Hamza Mohamed: Key Highlights from the 2026 AHA/ACC Multisociety Guideline on Acute PE
-
Jul 6, 2026, 18:58Mostafa Faisal: High PNH Type II Neutrophil Proportions Are Associated With Thrombosis
-
Jul 6, 2026, 17:57When Hematocrit Exceeds 70 Percent: Challenges in Peripheral Blood Smear Evaluation and CBC Analysis – Seema Dawood